Susquehanna International Group, LLP Kempharm, Inc Call Options Transaction History

Susquehanna International Group, LLP

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	N/A	55,600 Added 459.5%	67,700 $334,000
Q2 2024 Aug 15, 2024	SELL	N/A	-27,200 Reduced 69.21%	12,100 $59,000
Q1 2024 May 07, 2024	BUY	N/A	20,700 Added 111.29%	39,300 $194,000
Q4 2023 Feb 14, 2024	SELL	N/A	-28,200 Reduced 60.26%	18,600 $91,000
Q3 2023 Nov 14, 2023	SELL	N/A	-108,400 Reduced 69.85%	46,800 $231,000
Q2 2023 Aug 11, 2023	BUY	$4.94 - $6.29 $265,772 - $338,402	53,800 Added 53.06%	155,200 $766,000
Q1 2023 May 16, 2023	SELL	$4.13 - $6.27 $193,284 - $293,436	-46,800 Reduced 31.58%	101,400 $557,000
Q4 2022 Feb 14, 2023	SELL	$4.12 - $5.62 $271,096 - $369,796	-65,800 Reduced 30.75%	148,200 $680,000
Q3 2022 Nov 14, 2022	BUY	$4.5 - $6.85 $87,300 - $132,890	19,400 Added 9.97%	214,000 $1.34 Million
Q2 2022 Aug 15, 2022	SELL	$4.02 - $5.21 $422,501 - $547,571	-105,100 Reduced 35.07%	194,600 $868,000
Q1 2022 May 16, 2022	SELL	$5.0 - $9.26 $3.14 Million - $5.81 Million	-627,300 Reduced 67.67%	299,700 $1.51 Million
Q4 2021 Feb 14, 2022	BUY	$7.6 - $10.26 $4.48 Million - $6.04 Million	589,100 Added 174.34%	927,000 $8.07 Million
Q3 2021 Nov 15, 2021	BUY	$8.72 - $13.31 $782,184 - $1.19 Million	89,700 Added 36.14%	337,900 $3.15 Million
Q2 2021 Aug 11, 2021	SELL	$8.52 - $15.47 $391,068 - $710,073	-45,900 Reduced 15.61%	248,200 $3.18 Million
Q1 2021 May 17, 2021	BUY	$5.6 - $13.47 $1.65 Million - $3.96 Million	294,100 New	294,100 $2.71 Million

115

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.